AAKALU GIRISH N (CHIEF BUSINESS OFFICER) sold 3.1% of their position (2.40K shares) of GENOCEA BIOSCIENCES, INC. on the open market
Open‑market sale worth $2.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/17/2022ACC: 0001457612-22-000024
Officer· CHIEF BUSINESS OFFICER
Since Dec 2018
+122.60K
Net shares
Net buyer
$2.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
125K acquired · 2.40K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+31.25K
Price / share
—
Trade value
—
% of position
67.1%
3/15/2022
46.57K→77.82K
Common Stock
Direct
Shares
−2.40K
Price / share
$1.10
Trade value
$2.64K
% of position
3.1%
3/16/2022
77.82K→75.42K
Total
Net shares
+28.85K
Net value
-$2.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/15/2022 | A · Award | +31.25K | — | — | 67.1% | 46.57K | 77.82K |
| Common Stock Direct | 3/16/2022 | S · Sale | −2.40K | $1.10 | $2.64K | 3.1% | 77.82K | 75.42K |
| Total | +28.85K | -$2.64K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
93.75K shares
Shares
+93.75K
Strike price
1.11
Held after
93.75K
Exercisable
—
3/15/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock93.75K shares | 3/15/2022 | A · Award | +93.75K | 1.11 | — | 93.75K |